Ashwagandha Supplement
Effectiveness is solid due to alignment with 120-600 mg evidence-based dosing from 36 RCTs/meta-analyses (Akhgarjand 2022), though 4.5 mg withanolides is lower than premium extracts (15 mg). Safety excellent per trial data, rare issues only in cases not linked to this product. Quality good via transparency/Kosher but lacks gold-standard testing like NSF/USP. Overall balanced for stress support at moderate dose.
Excellent (83/100) - Effectiveness scores 82 due to robust RCT/meta-analysis support for stress reduction (e.g., 2022 meta-analysis Phytother Res showing cortisol drop, HAM-A score improvements at 300-600mg/day root extract), aligning with Bryan Johnson's use, but longevity claims lack human RCTs beyond indirect antioxidant/stress effects. Safety at 94 reflects excellent tolerability in trials (e.g., no dropouts from AEs in 90-day RCT PubMed 34858513) and absence of major risks. Quality at 68 penalizes lack of verified testing/transparency for this generic entry; superior if NSF/USP certified. Weighted overall 81 reflects strong evidence-based benefits outweighing quality gaps for stress-focused use.